Verastem Oncology
MA - NeedhamBiotechnology
Focus: Verastem Oncology is a mid-cap biotech focused on drugs targeting cancer stem cells, with primary expertise in oncology and cell therapy modalities. Based in Needham, MA, the company is actively commercializing and advancing a focused pipeline in solid tumors.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
14-4 this month
Stable — net -4 jobs in 30d
4 added, 8 removed. Backfill posture.
Should You Work at Verastem Oncology?
AI assessmentBest suited for professionals seeking commercial or clinical-stage exposure at a focused oncology biotech with near-term launch catalysts but limited pipeline diversity.
Why Work Here
- Recently launched AVMAPKI FAKZYNJA co-pack combination for ovarian cancer provides exposure to commercial execution of a novel dual-mechanism asset
- Focused pipeline with Phase 3 program in low-grade serous ovarian cancer offers clear near-term catalysts and clinical development momentum
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
AVMAPKI FAKZYNJA CO-PACK
Growing
Growth16.7yr
Novel dual MEK/FAK inhibitor combination recently launched with long 18-year LOE exclusivity window, targeting KRAS-mutant and low-grade serous ovarian cancers.
Products & Portfolio (1)
Help build intelligence for Verastem Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.